Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Medications for PCOS don't seem to raise heart disease risk.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Methylene blue, combined with ceramides, may reduce skin and hair side effects from GLP-1 therapy.

PCOS treatment should be personalized based on individual symptoms and health goals.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

GLP-1 agonists may increase the risk of hair loss.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Hair loss from weight-loss treatments is usually temporary and reversible.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Individualized treatments may help manage Dercum's disease symptoms.

Pharmacists play a crucial role in patient education and personalized care.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Community pharmacies and pharmacists play a crucial role in improving community health.

GLP-1 medications can cause skin and muscle issues, but treatments like ultrasound and PRP can help.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

PCOS is best managed with personalized lifestyle changes, medications, and sometimes surgery.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Ganoderma lucidum may help treat enlarged prostate in rats.